Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

184 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correction: a phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic HER2-negative breast cancer.
Shatsky RA, Batra-Sharma H, Helsten T, Schwab RB, Pittman EI, Pu M, Weihe E, Ghia EM, Rassenti LZ, Molinolo A, Cabrera B, Breitmeyer JB, Widhopf Ii GF, Messer K, Jamieson C, Kipps TJ, Parker BA. Shatsky RA, et al. Among authors: parker ba. Breast Cancer Res. 2024 Mar 13;26(1):46. doi: 10.1186/s13058-024-01805-w. Breast Cancer Res. 2024. PMID: 38481291 Free PMC article. No abstract available.
Evaluation of ultra-deep targeted sequencing for personalized breast cancer care.
Harismendy O, Schwab RB, Alakus H, Yost SE, Matsui H, Hasteh F, Wallace AM, Park HL, Madlensky L, Parker B, Carpenter PM, Jepsen K, Anton-Culver H, Frazer KA. Harismendy O, et al. Breast Cancer Res. 2013 Dec 10;15(6):R115. doi: 10.1186/bcr3584. Breast Cancer Res. 2013. PMID: 24326041 Free PMC article.
HER2 aberrations in cancer: implications for therapy.
Yan M, Parker BA, Schwab R, Kurzrock R. Yan M, et al. Among authors: parker ba. Cancer Treat Rev. 2014 Jul;40(6):770-80. doi: 10.1016/j.ctrv.2014.02.008. Epub 2014 Mar 12. Cancer Treat Rev. 2014. PMID: 24656976
Molecular tumor board: the University of California-San Diego Moores Cancer Center experience.
Schwaederle M, Parker BA, Schwab RB, Fanta PT, Boles SG, Daniels GA, Bazhenova LA, Subramanian R, Coutinho AC, Ojeda-Fournier H, Datnow B, Webster NJ, Lippman SM, Kurzrock R. Schwaederle M, et al. Among authors: parker ba. Oncologist. 2014 Jun;19(6):631-6. doi: 10.1634/theoncologist.2013-0405. Epub 2014 May 5. Oncologist. 2014. PMID: 24797821 Free PMC article.
Cyclin alterations in diverse cancers: Outcome and co-amplification network.
Schwaederlé M, Daniels GA, Piccioni DE, Fanta PT, Schwab RB, Shimabukuro KA, Parker BA, Kurzrock R. Schwaederlé M, et al. Among authors: parker ba. Oncotarget. 2015 Feb 20;6(5):3033-42. doi: 10.18632/oncotarget.2848. Oncotarget. 2015. PMID: 25596748 Free PMC article.
184 results